What medication is recommended for treating nocturnal enuresis (bedwetting)?

Medication for Bedwetting

Desmopressin (0.2-0.4 mg oral tablets taken 1 hour before bedtime) is the recommended first-line medication for treating nocturnal enuresis, with immediate effect in approximately 30% achieving complete dryness and 40% showing partial response. 1

First-Line Pharmacotherapy: Desmopressin

Desmopressin is the evidence-based first-line medication (grade Ia evidence) for bedwetting 1. The drug works by reducing nocturnal urine production and is particularly effective in children with nocturnal polyuria (nighttime urine production >130% of expected bladder capacity) 1.

Dosing and Administration

• Oral tablets: 0.2-0.4 mg taken at least 1 hour before sleep
• Oral melt formulation: 120-240 mg taken 30-60 minutes before bedtime
• Dose is not weight or age-dependent 1
• Anti-enuretic effect appears immediately 1
• Can be used daily or only before important nights 1

Critical Safety Concern

The single most important safety issue is water intoxication leading to hyponatremia and seizures 1. To prevent this:

• Limit evening fluid intake to 200 ml (6 ounces) or less with no drinking until morning 1
• Avoid nasal spray formulation - oral formulations are strongly preferred due to higher risk of water intoxication with nasal spray 1
• Polydipsia is an absolute contraindication 1

Limitations

The major drawback is low curative potential - most children relapse after stopping treatment 1. Regular drug holidays are essential to assess ongoing need 1.

Second-Line: Anticholinergics (For Treatment-Resistant Cases)

Anticholinergics (oxybutynin, tolterodine, propiverine) are only indicated when standard treatment has failed 1. They are not evidence-based first-line therapy 1.

Before Prescribing Anticholinergics - Mandatory Steps:

1. Try nonpharmacological methods first (regular voiding habits)
2. Exclude or treat constipation
3. Complete frequency-volume chart
4. Perform uroflowmetry with post-void residual measurement 1

Combination Therapy

Anticholinergics combined with desmopressin are effective in approximately 40% of treatment-resistant children 1. Recent high-quality evidence shows:

• Desmopressin plus oxybutynin: 33% failure rate versus 78% for placebo 1
• Combination therapy shows better outcomes than desmopressin monotherapy 2

Dosing

• Tolterodine: 2 mg at bedtime (may double)
• Oxybutynin: 5 mg at bedtime (may double)
• Propiverine: 0.4 mg/kg at bedtime (may double)
• Effect should appear within maximum 2 months 1

Side Effects to Monitor

• Constipation (most bothersome, may herald decreasing effectiveness)
• Post-void residual urine leading to UTIs (greatest danger)
• Mood changes (less common with tolterodine/propiverine than oxybutynin) 1

Third-Line: Imipramine (Tertiary Care Only)

Imipramine is only relevant as third-line therapy at tertiary care facilities due to safety concerns 1. It shows 50% response rate but has significant risks 1.

When to Consider

• Alarm therapy has failed AND family cannot afford desmopressin 1
• Treatment-resistant cases at specialized centers 1

Dosing

• 25 mg at bedtime for children ≤9 years
• 50 mg at bedtime for children >9 years
• Evaluate after 1 month 1

Critical Safety Requirements

Imipramine is potentially cardiotoxic and fatal in overdose 1. Before prescribing:

• Obtain baseline ECG to exclude long QT syndrome if any history of palpitations, syncope, sudden cardiac death, or unstable arrhythmia in family 1
• Keep medication securely locked away from younger siblings 1
• Monitor for mood changes, nausea, insomnia 1

Relapse Prevention

• Taper to lowest effective dose
• Regular drug holidays of at least 2 weeks every 3 months to decrease tolerance risk 1

Emerging Evidence: Mirabegron

Very recent 2026 research suggests mirabegron 25 mg may be superior to desmopressin with better outcomes, fewer relapses (10.7% vs 22.7%), and increased bladder capacity 3. However, this is single-study evidence and not yet incorporated into guidelines.

Comparative Effectiveness

Alarm therapy remains superior to all medications for long-term cure 4, 5. While desmopressin and alarms show similar short-term effectiveness, alarm therapy demonstrates:

• Better sustained effect after treatment cessation
• Lower relapse rates (58% vs 100% for imipramine) 6
• 96% relapse rate for desmopressin versus lower rates for alarm 1

Treatment Algorithm

1. Start with desmopressin if medication is chosen (particularly for nocturnal polyuria or when alarm unlikely to be used)
2. Add anticholinergic if desmopressin fails after adequate trial and proper evaluation completed
3. Consider imipramine only at tertiary centers if both above fail and cost is prohibitive
4. Always restrict evening fluids to 200 ml or less with desmopressin
5. Institute regular drug holidays to assess ongoing need

Common Pitfalls to Avoid

• Using nasal spray desmopressin (higher seizure risk)
• Failing to restrict fluids adequately with desmopressin
• Starting anticholinergics without proper bladder assessment
• Not monitoring for post-void residual with anticholinergics
• Prescribing imipramine without cardiac screening when indicated
• Expecting permanent cure from medications alone